Mixed blast crisis of chronic myelogenous leukemia involving minimally differentiated myeloblast and megakaryoblast lineages [2]

Laboratory Hematology

Volumn 10, Issue 4, 2004, Pages 254-255

  Amemiya, Norihiko ^a   Yatomi, Yutaka ^b   Yanagi, Mitsuaki ^a   Endo, Takeshi ^a   Ozaki, Yukio ^a  

^a YAMANASHI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; MESSENGER RNA;

ADULT; BLAST CELL CRISIS; BLOOD EXAMINATION; CANCER CONTROL; CANCER DIAGNOSIS; CASE REPORT; CELL DIFFERENTIATION; CELL LINEAGE; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; FEMALE; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LETTER; LEUKEMIA CELL; LEUKOCYTOSIS; MEGAKARYOBLAST; MORPHOLOGY; MYELOBLAST; PATIENT REFERRAL; POLYMERASE CHAIN REACTION;

BLAST CRISIS; CELL DIFFERENTIATION; CELL LINEAGE; FEMALE; GRANULOCYTE PRECURSOR CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MEGAKARYOCYTES; MIDDLE AGED;

EID: 11244352143     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: 10.1532/LH96.04024     Document Type: Letter

References (6)

1. Faderl S, Talpaz M, Estrov Z, Kantarjian HM. Chronic myelogenous leukemia: biology and therapy. Ann Intern Med. 1999;131:207-219.
2. Saikia T, Advani S, Dasgupta A, et al. Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping-experience in 60 patients. Leuk Res. 1988;12:499-506.
3. Venditti A, Del Poeta G, Buccisano F, et al. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes. Blood. 1997;89:621-629.
4. San Miguel JF, Gonzalez M, Canizo MC, et al. Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics. Blood. 1988;72:402-407.
5. Shibata K, Nakano S, Watanabe M, Yano H, Matsuzaki M, Sano M. Acute megakaryocytic leukaemia (AML-M7) with myelofibrosis terminating in AML-MO with concurrent liver fibrosis. Eur J Haematol 1998;60: 310-312.
6. Matsuo Y, Drexler HG, Kaneda K, et al. Megakaryoblastic leukemia cell line MOLM-16 derived from minimally differentiated acute leukemia with myeloid/NK precursor phenotype. Leuk Res. 2003;27:165-171.